1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bio Pharma Buffer Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Published Date: April 2024
|
Report Code: QYRE-Auto-31T429
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bio Pharma Buffer Market Insights and Forecast to 2028
BUY CHAPTERS

Global Bio Pharma Buffer Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Code: QYRE-Auto-31T429
Report
April 2024
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bio Pharma Buffer Market Size

The global Bio Pharma Buffer market is projected to reach US$ 1376.7 million by 2030 from an estimated US$ 907.1 million in 2024, at a CAGR of 7.2% during 2024 and 2030.

Bio Pharma Buffer Market

Bio Pharma Buffer Market

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bio Pharma Buffer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Bio Pharma Buffer.
The Bio Pharma Buffer market size, estimations, and forecasts are provided in terms of sales volume (K Liter) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio Pharma Buffer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio Pharma Buffer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation

Scope of Bio Pharma Buffer Market Report

Report Metric Details
Report Name Bio Pharma Buffer Market
Accounted market size in 2024 an estimated US$ 907.1 million
Forecasted market size in 2030 US$ 1376.7 million
CAGR 7.2%
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Phosphates Type
  • Acetates Type
  • TRIS Type
  • Others
Segment by Application
  • Research Institution
  • Pharmaceutical Industry
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Bio Pharma Buffer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Bio Pharma Buffer manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio Pharma Buffer sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Bio Pharma Buffer Market growing?

Ans: The Bio Pharma Buffer Market witnessing a CAGR of 7.2% during the forecast period 2024-2030.

What is the Bio Pharma Buffer Market size in 2030?

Ans: The Bio Pharma Buffer Market size in 2030 will be US$ 1376.7 million.

What is the market share of major companies in Bio Pharma Buffer Market?

Ans: Because the top 6 companies have more than 70% market share.

Who are the main players in the Bio Pharma Buffer Market report?

Ans: The main players in the Bio Pharma Buffer Market are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL

What are the Application segmentation covered in the Bio Pharma Buffer Market report?

Ans: The Applications covered in the Bio Pharma Buffer Market report are Research Institution, Pharmaceutical Industry, Others

What are the Type segmentation covered in the Bio Pharma Buffer Market report?

Ans: The Types covered in the Bio Pharma Buffer Market report are Phosphates Type, Acetates Type, TRIS Type, Others

1 Study Coverage
1.1 Bio Pharma Buffer Product Introduction
1.2 Market by Type
1.2.1 Global Bio Pharma Buffer Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Phosphates Type
1.2.3 Acetates Type
1.2.4 TRIS Type
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bio Pharma Buffer Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Research Institution
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bio Pharma Buffer Market Size Estimates and Forecasts
2.1.1 Global Bio Pharma Buffer Revenue 2019-2030
2.1.2 Global Bio Pharma Buffer Sales 2019-2030
2.2 Bio Pharma Buffer Market Size by Region: 2023 Versus 2030
2.3 Bio Pharma Buffer Sales by Region (2019-2030)
2.3.1 Global Bio Pharma Buffer Sales by Region: 2019-2024
2.3.2 Global Bio Pharma Buffer Sales Forecast by Region (2025-2030)
2.3.3 Global Bio Pharma Buffer Sales Market Share by Region (2019-2030)
2.4 Bio Pharma Buffer Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Bio Pharma Buffer Revenue by Region: 2019-2024
2.4.2 Global Bio Pharma Buffer Revenue Forecast by Region (2025-2030)
2.4.3 Global Bio Pharma Buffer Revenue Market Share by Region (2019-2030)
3 Global Bio Pharma Buffer by Manufacturers
3.1 Global Top Bio Pharma Buffer Manufacturers by Sales
3.1.1 Global Bio Pharma Buffer Sales by Manufacturer (2019-2024)
3.1.2 Global Bio Pharma Buffer Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Bio Pharma Buffer Manufacturers by Revenue
3.2.1 Global Bio Pharma Buffer Revenue by Manufacturer (2019-2024)
3.2.2 Global Bio Pharma Buffer Revenue Share by Manufacturer (2019-2024)
3.3 Global Bio Pharma Buffer Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Bio Pharma Buffer Manufacturers Covered: Ranking by Revenue
3.4.2 Global Bio Pharma Buffer Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Bio Pharma Buffer Manufacturing Base Distribution, Product Type
3.5.1 Bio Pharma Buffer Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Bio Pharma Buffer Product Type
3.5.3 Date of International Manufacturers Enter into Bio Pharma Buffer Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Avantor
4.1.1 Avantor Company Information
4.1.2 Avantor Description, Business Overview
4.1.3 Avantor Bio Pharma Buffer Products Offered
4.1.4 Avantor Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Avantor Bio Pharma Buffer Sales by Product in 2023
4.1.6 Avantor Bio Pharma Buffer Sales by Application in 2023
4.1.7 Avantor Bio Pharma Buffer Sales by Geographic Area in 2023
4.1.8 Avantor Recent Developments
4.2 Alfa Aesar (Thermo Fisher)
4.2.1 Alfa Aesar (Thermo Fisher) Company Information
4.2.2 Alfa Aesar (Thermo Fisher) Description, Business Overview
4.2.3 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Products Offered
4.2.4 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales by Product in 2023
4.2.6 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales by Application in 2023
4.2.7 Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales by Geographic Area in 2023
4.2.8 Alfa Aesar (Thermo Fisher) Recent Developments
4.3 Merck
4.3.1 Merck Company Information
4.3.2 Merck Description, Business Overview
4.3.3 Merck Bio Pharma Buffer Products Offered
4.3.4 Merck Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Merck Bio Pharma Buffer Sales by Product in 2023
4.3.6 Merck Bio Pharma Buffer Sales by Application in 2023
4.3.7 Merck Bio Pharma Buffer Sales by Geographic Area in 2023
4.3.8 Merck Recent Developments
4.4 Lonza
4.4.1 Lonza Company Information
4.4.2 Lonza Description, Business Overview
4.4.3 Lonza Bio Pharma Buffer Products Offered
4.4.4 Lonza Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Lonza Bio Pharma Buffer Sales by Product in 2023
4.4.6 Lonza Bio Pharma Buffer Sales by Application in 2023
4.4.7 Lonza Bio Pharma Buffer Sales by Geographic Area in 2023
4.4.8 Lonza Recent Developments
4.5 Bio-Rad
4.5.1 Bio-Rad Company Information
4.5.2 Bio-Rad Description, Business Overview
4.5.3 Bio-Rad Bio Pharma Buffer Products Offered
4.5.4 Bio-Rad Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Bio-Rad Bio Pharma Buffer Sales by Product in 2023
4.5.6 Bio-Rad Bio Pharma Buffer Sales by Application in 2023
4.5.7 Bio-Rad Bio Pharma Buffer Sales by Geographic Area in 2023
4.5.8 Bio-Rad Recent Developments
4.6 BD
4.6.1 BD Company Information
4.6.2 BD Description, Business Overview
4.6.3 BD Bio Pharma Buffer Products Offered
4.6.4 BD Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.6.5 BD Bio Pharma Buffer Sales by Product in 2023
4.6.6 BD Bio Pharma Buffer Sales by Application in 2023
4.6.7 BD Bio Pharma Buffer Sales by Geographic Area in 2023
4.6.8 BD Recent Development
4.7 GE Healthcare
4.7.1 GE Healthcare Company Information
4.7.2 GE Healthcare Description, Business Overview
4.7.3 GE Healthcare Bio Pharma Buffer Products Offered
4.7.4 GE Healthcare Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.7.5 GE Healthcare Bio Pharma Buffer Sales by Product in 2023
4.7.6 GE Healthcare Bio Pharma Buffer Sales by Application in 2023
4.7.7 GE Healthcare Bio Pharma Buffer Sales by Geographic Area in 2023
4.7.8 GE Healthcare Recent Development
4.8 Promega Corporation
4.8.1 Promega Corporation Company Information
4.8.2 Promega Corporation Description, Business Overview
4.8.3 Promega Corporation Bio Pharma Buffer Products Offered
4.8.4 Promega Corporation Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.8.5 Promega Corporation Bio Pharma Buffer Sales by Product in 2023
4.8.6 Promega Corporation Bio Pharma Buffer Sales by Application in 2023
4.8.7 Promega Corporation Bio Pharma Buffer Sales by Geographic Area in 2023
4.8.8 Promega Corporation Recent Development
4.9 Hamilton Company
4.9.1 Hamilton Company Company Information
4.9.2 Hamilton Company Description, Business Overview
4.9.3 Hamilton Company Bio Pharma Buffer Products Offered
4.9.4 Hamilton Company Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Hamilton Company Bio Pharma Buffer Sales by Product in 2023
4.9.6 Hamilton Company Bio Pharma Buffer Sales by Application in 2023
4.9.7 Hamilton Company Bio Pharma Buffer Sales by Geographic Area in 2023
4.9.8 Hamilton Company Recent Development
4.10 XZL BIO-TECHNOLOGY
4.10.1 XZL BIO-TECHNOLOGY Company Information
4.10.2 XZL BIO-TECHNOLOGY Description, Business Overview
4.10.3 XZL BIO-TECHNOLOGY Bio Pharma Buffer Products Offered
4.10.4 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.10.5 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales by Product in 2023
4.10.6 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales by Application in 2023
4.10.7 XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales by Geographic Area in 2023
4.10.8 XZL BIO-TECHNOLOGY Recent Development
4.11 SRL
4.11.1 SRL Company Information
4.11.2 SRL Description, Business Overview
4.11.3 SRL Bio Pharma Buffer Products Offered
4.11.4 SRL Bio Pharma Buffer Sales, Revenue and Gross Margin (2019-2024)
4.11.5 SRL Bio Pharma Buffer Sales by Product in 2023
4.11.6 SRL Bio Pharma Buffer Sales by Application in 2023
4.11.7 SRL Bio Pharma Buffer Sales by Geographic Area in 2023
4.11.8 SRL Recent Development
5 Breakdown Data by Type
5.1 Global Bio Pharma Buffer Sales by Type (2019-2030)
5.1.1 Global Bio Pharma Buffer Sales by Type (2019-2024)
5.1.2 Global Bio Pharma Buffer Sales Forecast by Type (2025-2030)
5.1.3 Global Bio Pharma Buffer Sales Market Share by Type (2019-2030)
5.2 Global Bio Pharma Buffer Revenue Forecast by Type (2019-2030)
5.2.1 Global Bio Pharma Buffer Revenue by Type (2019-2024)
5.2.2 Global Bio Pharma Buffer Revenue Forecast by Type (2025-2030)
5.2.3 Global Bio Pharma Buffer Revenue Market Share by Type (2019-2030)
5.3 Bio Pharma Buffer Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Bio Pharma Buffer Sales by Application (2019-2030)
6.1.1 Global Bio Pharma Buffer Sales by Application (2019-2024)
6.1.2 Global Bio Pharma Buffer Sales Forecast by Application (2025-2030)
6.1.3 Global Bio Pharma Buffer Sales Market Share by Application (2019-2030)
6.2 Global Bio Pharma Buffer Revenue Forecast by Application (2019-2030)
6.2.1 Global Bio Pharma Buffer Revenue by Application (2019-2024)
6.2.2 Global Bio Pharma Buffer Revenue Forecast by Application (2025-2030)
6.2.3 Global Bio Pharma Buffer Revenue Market Share by Application (2019-2030)
6.3 Bio Pharma Buffer Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Bio Pharma Buffer Market Size YoY Growth 2019-2030
7.2 North America Bio Pharma Buffer Market Facts & Figures by Country
7.2.1 North America Bio Pharma Buffer Sales by Country (2019-2030)
7.2.2 North America Bio Pharma Buffer Revenue by Country (2019-2030)
7.3 North America Bio Pharma Buffer Sales by Type (2019-2024)
7.4 North America Bio Pharma Buffer Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Bio Pharma Buffer Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Bio Pharma Buffer Market Facts & Figures by Region
8.2.1 Asia-Pacific Bio Pharma Buffer Sales by Region (2019-2030)
8.2.2 Asia-Pacific Bio Pharma Buffer Revenue by Region (2019-2030)
8.3 Asia-Pacific Bio Pharma Buffer Sales by Type (2019-2024)
8.4 Asia-Pacific Bio Pharma Buffer Sales by Application (2019-2024)
9 Europe
9.1 Europe Bio Pharma Buffer Market Size YoY Growth 2019-2030
9.2 Europe Bio Pharma Buffer Market Facts & Figures by Country
9.2.1 Europe Bio Pharma Buffer Sales by Country (2019-2030)
9.2.2 Europe Bio Pharma Buffer Revenue by Country (2019-2030)
9.3 Europe Bio Pharma Buffer Sales by Type (2019-2024)
9.4 Europe Bio Pharma Buffer Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Bio Pharma Buffer Market Size YoY Growth 2019-2030
10.2 Latin America Bio Pharma Buffer Market Facts & Figures by Country
10.2.1 Latin America Bio Pharma Buffer Sales by Country (2019-2030)
10.2.2 Latin America Bio Pharma Buffer Revenue by Country (2019-2030)
10.3 Latin America Bio Pharma Buffer Sales by Type (2019-2024)
10.4 Latin America Bio Pharma Buffer Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Bio Pharma Buffer Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Bio Pharma Buffer Market Facts & Figures by Country
11.2.1 Middle East and Africa Bio Pharma Buffer Sales by Country (2019-2030)
11.2.2 Middle East and Africa Bio Pharma Buffer Revenue by Country (2019-2030)
11.3 Middle East and Africa Bio Pharma Buffer Sales by Type (2019-2024)
11.4 Middle East and Africa Bio Pharma Buffer Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Bio Pharma Buffer Supply Chain Analysis
12.2 Bio Pharma Buffer Key Raw Materials and Upstream Suppliers
12.3 Bio Pharma Buffer Clients Analysis
12.4 Bio Pharma Buffer Sales Channel and Sales Model Analysis
12.4.1 Bio Pharma Buffer Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Bio Pharma Buffer Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Bio Pharma Buffer Distributors
13 Market Dynamics
13.1 Bio Pharma Buffer Industry Trends
13.2 Bio Pharma Buffer Market Drivers
13.3 Bio Pharma Buffer Market Challenges
13.4 Bio Pharma Buffer Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Bio Pharma Buffer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Major Manufacturers of Phosphates Type
    Table 3. Major Manufacturers of Acetates Type
    Table 4. Major Manufacturers of TRIS Type
    Table 5. Major Manufacturers of Others
    Table 6. Global Bio Pharma Buffer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Bio Pharma Buffer Market Size by Region (US$ Million): 2023 VS 2030
    Table 8. Global Bio Pharma Buffer Sales by Region (2019-2024) & (K Liter)
    Table 9. Global Bio Pharma Buffer Sales Forecast by Region (2025-2030) & (K Liter)
    Table 10. Global Bio Pharma Buffer Revenue by Region (2019-2024) & (US$ Million)
    Table 11. Global Bio Pharma Buffer Revenue Forecast by Region (2025-2030) & (US$ Million)
    Table 12. Global Bio Pharma Buffer Sales by Manufacturer (2019-2024) & (K Liter)
    Table 13. Global Bio Pharma Buffer Sales Share by Manufacturer (2019-2024)
    Table 14. Bio Pharma Buffer Revenue by Manufacturer (2019-2024) & (US$ Million)
    Table 15. Bio Pharma Buffer Revenue Share by Manufacturer (2019-2024)
    Table 16. Key Manufacturers Bio Pharma Buffer Price (2019-2024) & (USD/Liter)
    Table 17. Ranking of Global Top Bio Pharma Buffer Manufacturers by Revenue (US$ Million) in 2023
    Table 18. Global Bio Pharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)
    Table 19. Global Bio Pharma Buffer by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio Pharma Buffer as of 2023)
    Table 20. Bio Pharma Buffer Manufacturers Manufacturing Base Distribution and Headquarters
    Table 21. Manufacturers Bio Pharma Buffer Product Type
    Table 22. Date of International Manufacturers Enter into Bio Pharma Buffer Market
    Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 24. Avantor Company Information
    Table 25. Avantor Description and Business Overview
    Table 26. Avantor Bio Pharma Buffer Product
    Table 27. Avantor Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 28. Avantor Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 29. Avantor Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 30. Avantor Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 31. Avantor Recent Development
    Table 32. Alfa Aesar (Thermo Fisher) Company Information
    Table 33. Alfa Aesar (Thermo Fisher) Description and Business Overview
    Table 34. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Product
    Table 35. Alfa Aesar (Thermo Fisher) Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 36. Alfa Aesar (Thermo Fisher) Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 37. Alfa Aesar (Thermo Fisher) Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 38. Alfa Aesar (Thermo Fisher) Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 39. Alfa Aesar (Thermo Fisher) Recent Development
    Table 40. Merck Company Information
    Table 41. Merck Description and Business Overview
    Table 42. Merck Bio Pharma Buffer Product
    Table 43. Merck Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 44. Merck Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 45. Merck Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 46. Merck Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 47. Merck Recent Development
    Table 48. Lonza Company Information
    Table 49. Lonza Description and Business Overview
    Table 50. Lonza Bio Pharma Buffer Product
    Table 51. Lonza Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 52. Lonza Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 53. Lonza Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 54. Lonza Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 55. Lonza Recent Development
    Table 56. Bio-Rad Company Information
    Table 57. Bio-Rad Description and Business Overview
    Table 58. Bio-Rad Bio Pharma Buffer Product
    Table 59. Bio-Rad Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 60. Bio-Rad Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 61. Bio-Rad Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 62. Bio-Rad Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 63. Bio-Rad Recent Development
    Table 64. BD Company Information
    Table 65. BD Description and Business Overview
    Table 66. BD Bio Pharma Buffer Product
    Table 67. BD Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 68. BD Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 69. BD Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 70. BD Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 71. BD Recent Development
    Table 72. GE Healthcare Company Information
    Table 73. GE Healthcare Description and Business Overview
    Table 74. GE Healthcare Bio Pharma Buffer Product
    Table 75. GE Healthcare Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 76. GE Healthcare Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 77. GE Healthcare Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 78. GE Healthcare Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 79. GE Healthcare Recent Development
    Table 80. Promega Corporation Company Information
    Table 81. Promega Corporation Description and Business Overview
    Table 82. Promega Corporation Bio Pharma Buffer Product
    Table 83. Promega Corporation Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 84. Promega Corporation Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 85. Promega Corporation Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 86. Promega Corporation Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 87. Promega Corporation Recent Development
    Table 88. Hamilton Company Company Information
    Table 89. Hamilton Company Description and Business Overview
    Table 90. Hamilton Company Bio Pharma Buffer Product
    Table 91. Hamilton Company Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 92. Hamilton Company Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 93. Hamilton Company Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 94. Hamilton Company Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 95. Hamilton Company Recent Development
    Table 96. XZL BIO-TECHNOLOGY Company Information
    Table 97. XZL BIO-TECHNOLOGY Description and Business Overview
    Table 98. XZL BIO-TECHNOLOGY Bio Pharma Buffer Product
    Table 99. XZL BIO-TECHNOLOGY Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 100. XZL BIO-TECHNOLOGY Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 101. XZL BIO-TECHNOLOGY Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 102. XZL BIO-TECHNOLOGY Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 103. XZL BIO-TECHNOLOGY Recent Development
    Table 104. SRL Company Information
    Table 105. SRL Description and Business Overview
    Table 106. SRL Bio Pharma Buffer Product
    Table 107. SRL Bio Pharma Buffer Sales (K Liter), Revenue (US$ Million), Price (USD/Liter) and Gross Margin (2019-2024)
    Table 108. SRL Sales Proportion of Bio Pharma Buffer by Product in 2023
    Table 109. SRL Sales Proportion of Bio Pharma Buffer by Application in 2023
    Table 110. SRL Sales Proportion of Bio Pharma Buffer by Geographic Area in 2023
    Table 111. SRL Recent Development
    Table 112. Global Bio Pharma Buffer Sales by Type (2019-2024) & (K Liter)
    Table 113. Global Bio Pharma Buffer Sales Forecast by Type (2025-2030) & (K Liter)
    Table 114. Global Bio Pharma Buffer Revenue by Type (2019-2024) & (US$ Million)
    Table 115. Global Bio Pharma Buffer Revenue Forecast by Type (2025-2030) & (US$ Million)
    Table 116. Global Bio Pharma Buffer Sales by Application (2019-2024) & (K Liter)
    Table 117. Global Bio Pharma Buffer Sales Forecast by Application (2025-2030) & (K Liter)
    Table 118. Global Bio Pharma Buffer Revenue by Application (2019-2024) & (US$ Million)
    Table 119. Global Bio Pharma Buffer Revenue Forecast by Application (2025-2030) & (US$ Million)
    Table 120. North America Bio Pharma Buffer Sales by Country (2019-2024) & (K Liter)
    Table 121. North America Bio Pharma Buffer Sales by Country (2025-2030) & (K Liter)
    Table 122. North America Bio Pharma Buffer Revenue by Country (2019-2024) & (US$ Million)
    Table 123. North America Bio Pharma Buffer Revenue by Country (2025-2030) & (US$ Million)
    Table 124. North America Bio Pharma Buffer Sales by Type (2019-2024) & (K Liter)
    Table 125. North America Bio Pharma Buffer Sales by Application (2019-2024) & (K Liter)
    Table 126. Asia-Pacific Bio Pharma Buffer Sales by Region (2019-2024) & (K Liter)
    Table 127. Asia-Pacific Bio Pharma Buffer Sales by Region (2025-2030) & (K Liter)
    Table 128. Asia-Pacific Bio Pharma Buffer Revenue by Region (2019-2030) & (US$ Million)
    Table 129. Asia-Pacific Bio Pharma Buffer Revenue by Region (2025-2030) & (US$ Million)
    Table 130. Asia-Pacific Bio Pharma Buffer Sales by Type (2019-2024) & (K Liter)
    Table 131. Asia-Pacific Bio Pharma Buffer Sales by Application (2019-2024) & (K Liter)
    Table 132. Europe Bio Pharma Buffer Sales by Country (2019-2024) & (K Liter)
    Table 133. Europe Bio Pharma Buffer Sales by Country (2025-2030) & (K Liter)
    Table 134. Europe Bio Pharma Buffer Revenue by Country (2019-2024) & (US$ Million)
    Table 135. Europe Bio Pharma Buffer Revenue by Country (2025-2030) & (US$ Million)
    Table 136. Europe Bio Pharma Buffer Sales by Type (2019-2024) & (K Liter)
    Table 137. Europe Bio Pharma Buffer Sales by Application (2019-2024) & (K Liter)
    Table 138. Latin America Bio Pharma Buffer Sales by Country (2019-2024) & (K Liter)
    Table 139. Latin America Bio Pharma Buffer Sales by Country (2025-2030) & (K Liter)
    Table 140. Latin America Bio Pharma Buffer Revenue by Country (2019-2024) & (US$ Million)
    Table 141. Latin America Bio Pharma Buffer Revenue by Country (2025-2030) & (US$ Million)
    Table 142. Latin America Bio Pharma Buffer Sales by Type (2019-2024) & (K Liter)
    Table 143. Latin America Bio Pharma Buffer Sales by Application (2019-2024) & (K Liter)
    Table 144. Middle East and Africa Bio Pharma Buffer Sales by Country (2019-2024) & (K Liter)
    Table 145. Middle East and Africa Bio Pharma Buffer Sales by Country (2025-2030) & (K Liter)
    Table 146. Middle East and Africa Bio Pharma Buffer Revenue by Country (2019-2024) & (US$ Million)
    Table 147. Middle East and Africa Bio Pharma Buffer Revenue by Country (2025-2030) & (US$ Million)
    Table 148. Middle East and Africa Bio Pharma Buffer Sales by Type (2019-2024) & (K Liter)
    Table 149. Middle East and Africa Bio Pharma Buffer Sales by Application (2019-2024) & (K Liter)
    Table 150. Bio Pharma Buffer Key Raw Materials, Industry Status and Trend
    Table 151. Bio Pharma Buffer Key Raw Materials and Upstream Suppliers
    Table 152. Bio Pharma Buffer Clients Status and Trend
    Table 153. Bio Pharma Buffer Typical Clients
    Table 154. Bio Pharma Buffer Distributors
    Table 155. Bio Pharma Buffer Market Trends
    Table 156. Bio Pharma Buffer Market Drivers
    Table 157. Bio Pharma Buffer Market Challenges
    Table 158. Bio Pharma Buffer Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bio Pharma Buffer Product Picture
    Figure 2. Global Bio Pharma Buffer Sales Market Share by Type in 2023 & 2030
    Figure 3. Phosphates Type Product Picture
    Figure 4. Acetates Type Product Picture
    Figure 5. TRIS Type Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Bio Pharma Buffer Sales Market Share by Application in 2023 & 2030
    Figure 8. Research Institution Examples
    Figure 9. Pharmaceutical Industry Examples
    Figure 10. Others Examples
    Figure 11. Bio Pharma Buffer Report Years Considered
    Figure 12. Global Bio Pharma Buffer Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Bio Pharma Buffer Market Size 2019-2030 (US$ Million)
    Figure 14. Global Bio Pharma Buffer Sales 2019-2030 (K Liter)
    Figure 15. Global Bio Pharma Buffer Sales Market Share Forecast by Region (2019-2030)
    Figure 16. Global Bio Pharma Buffer Revenue Market Share by Region (2019-2030)
    Figure 17. Global Bio Pharma Buffer Sales Share by Manufacturer in 2023
    Figure 18. Bio Pharma Buffer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Bio Pharma Buffer Sales Market Share Forecast by Type (2019-2030)
    Figure 20. Global Bio Pharma Buffer Revenue Market Share Forecast by Type (2019-2030)
    Figure 21. Bio Pharma Buffer Average Selling Price (ASP) by Type (2019-2024) & (USD/Liter)
    Figure 22. Global Bio Pharma Buffer Sales Market Share Forecast by Application (2019-2030)
    Figure 23. Global Bio Pharma Buffer Revenue Market Share Forecast by Application (2019-2030)
    Figure 24. Bio Pharma Buffer Average Selling Price (ASP) by Application (2019-2024) & (USD/Liter)
    Figure 25. North America Bio Pharma Buffer Revenue 2019-2030 (US$ Million)
    Figure 26. North America Bio Pharma Buffer Sales Market Share by Type (2019-2024)
    Figure 27. North America Bio Pharma Buffer Sales Market Share by Application (2019-2024)
    Figure 28. Asia-Pacific Bio Pharma Buffer Revenue 2019-2030 (US$ Million)
    Figure 29. Asia-Pacific Bio Pharma Buffer Sales Market Share by Region (2019-2030)
    Figure 30. Asia-Pacific Bio Pharma Buffer Revenue Market Share by Region (2019-2030)
    Figure 31. Asia-Pacific Bio Pharma Buffer Sales Market Share by Type (2019-2024)
    Figure 32. Asia-Pacific Bio Pharma Buffer Sales Market Share by Application (2019-2024)
    Figure 33. Europe Bio Pharma Buffer Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 34. Europe Bio Pharma Buffer Sales Market Share by Country (2019-2030)
    Figure 35. Europe Bio Pharma Buffer Revenue Market Share by Country (2019-2030)
    Figure 36. Europe Bio Pharma Buffer Sales Market Share by Type (2019-2024)
    Figure 37. Europe Bio Pharma Buffer Sales Market Share by Application (2019-2024)
    Figure 38. Latin America Bio Pharma Buffer Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 39. Latin America Bio Pharma Buffer Sales Market Share by Country (2019-2030)
    Figure 40. Latin America Bio Pharma Buffer Revenue Market Share by Country (2019-2024)
    Figure 41. Latin America Bio Pharma Buffer Sales Market Share by Type (2019-2024)
    Figure 42. Latin America Bio Pharma Buffer Sales Market Share by Application (2019-2024)
    Figure 43. Middle East and Africa Bio Pharma Buffer Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 44. Middle East and Africa Bio Pharma Buffer Sales Market Share by Country (2019-2030)
    Figure 45. Middle East and Africa Bio Pharma Buffer Revenue Market Share by Country (2019-2030)
    Figure 46. Middle East and Africa Bio Pharma Buffer Sales Market Share by Type (2019-2024)
    Figure 47. Middle East and Africa Bio Pharma Buffer Sales Market Share by Application (2019-2024)
    Figure 48. Bio Pharma Buffer Supply Chain (Upstream and Downstream Market)
    Figure 49. Global Production Market Share of Bio Pharma Buffer Raw Materials by Region in 2023
    Figure 50. Bio Pharma Buffer Distribution Channels
    Figure 51. Global Bio Pharma Buffer Percentage 2019-2030: Indirect Sales VS Direct Sales
    Figure 52. Global Bio Pharma Buffer Percentage 2019-2030: Online Sales VS Offline Sales
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Veterinary Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-31X6782
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Coating Devcie Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-7E13021
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Animal Antibacterial Peptide Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20G6893
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Medical Biological Indicator Incubator Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34Y12560
Fri May 17 00:00:00 UTC 2024

Add to Cart